Loading…

ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels

The authors have previously shown that individuals heterozygous for ABCA1 mutations have decreased high density lipoprotein cholesterol, increased triglycerides and an increased frequency of coronary artery disease (CAD), and that single nucleotide polymorphisms (SNPs) in the coding region of the AB...

Full description

Saved in:
Bibliographic Details
Published in:Clinical genetics 2002-02, Vol.61 (2), p.115-125
Main Authors: Zwarts, KY, Clee, SM, Zwinderman, AH, Engert, JC, Singaraja, R, Loubser, O, James, E, Roomp, K, Hudson, TJ, Jukema, JW, Kastelein, JJP, Hayden, MR
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4386-abe807cb67acf1d404a9c8b97a2a7bf461b8ab507216c6c1ef3916f15b6aa9823
cites cdi_FETCH-LOGICAL-c4386-abe807cb67acf1d404a9c8b97a2a7bf461b8ab507216c6c1ef3916f15b6aa9823
container_end_page 125
container_issue 2
container_start_page 115
container_title Clinical genetics
container_volume 61
creator Zwarts, KY
Clee, SM
Zwinderman, AH
Engert, JC
Singaraja, R
Loubser, O
James, E
Roomp, K
Hudson, TJ
Jukema, JW
Kastelein, JJP
Hayden, MR
description The authors have previously shown that individuals heterozygous for ABCA1 mutations have decreased high density lipoprotein cholesterol, increased triglycerides and an increased frequency of coronary artery disease (CAD), and that single nucleotide polymorphisms (SNPs) in the coding region of the ABCA1 gene significantly impact plasma lipid levels and the severity of CAD in the general population. They have now identified several SNPs in non‐coding regions of ABCA1 which may be important for the appropriate regulation of ABCA1 expression (i.e. in the promoter, intron 1 and the 5′ untranslated region), and have examined the phenotypic effects of these SNPs in the REGRESS population. Out of 12 SNPs, four were associated with a clinical outcome. A threefold increase in coronary events with an increased family history of CAD was evident for the G‐191C variant. Similarly, the C69T SNP was associated with a twofold increase in events. In contrast, the C‐17G was associated with a decrease in coronary events and the InsG319 was associated with less atherosclerosis. For all these SNPs, the changes in atherosclerosis and CAD occurred without detectable changes in plasma lipid levels. These data suggest that common variation in non‐coding regions of ABCA1 may significantly alter the severity of atherosclerosis, without necessarily influencing plasma lipid levels.
doi_str_mv 10.1034/j.1399-0004.2002.610206.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71588985</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71588985</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4386-abe807cb67acf1d404a9c8b97a2a7bf461b8ab507216c6c1ef3916f15b6aa9823</originalsourceid><addsrcrecordid>eNqNkUGP0zAQhS0EYsvCX0DhALcEO04c-0a3XQpSBQdAHK2JM0YubhLsZOn-e1yl2r1y8bM13zx7ngl5w2jBKK_eHwrGlcoppVVRUloWgtGSiuL0hKweKk_JKonKFRP8iryI8ZCOvKnVc3LFmKoolWJF3Ppms2ZZwF-zh2kI99kdBAf9FDPXWz9jbzAzQxh6SDUIEybpXESImIgOR0xLP2WDzdBaNKlx6LPRQzxC5t3ouszjHfr4kjyz4CO-uug1-fHx9vvmU77_uvu8We9zU3EpcmhR0sa0ogFjWVfRCpSRrWqghKa1lWCthLamTcmEEYah5WlCy-pWAChZ8mvybvEdw_Bnxjjpo4sGvYcehznqhtVSKlknUC2gCUOMAa0egzumMTWj-pyzPuhzmvqcpj7nrJec9Sn1vr5cMrdH7B47L8Em4O0FgGjA2wC9cfGR43XDuaCJ-7Bwf53H-_9_gd7sbpd9ssgXCxcnPD1YQPitRZM-XP_8stPf6HYr94LrLf8HlPKppQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71588985</pqid></control><display><type>article</type><title>ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels</title><source>Wiley</source><creator>Zwarts, KY ; Clee, SM ; Zwinderman, AH ; Engert, JC ; Singaraja, R ; Loubser, O ; James, E ; Roomp, K ; Hudson, TJ ; Jukema, JW ; Kastelein, JJP ; Hayden, MR</creator><creatorcontrib>Zwarts, KY ; Clee, SM ; Zwinderman, AH ; Engert, JC ; Singaraja, R ; Loubser, O ; James, E ; Roomp, K ; Hudson, TJ ; Jukema, JW ; Kastelein, JJP ; Hayden, MR</creatorcontrib><description>The authors have previously shown that individuals heterozygous for ABCA1 mutations have decreased high density lipoprotein cholesterol, increased triglycerides and an increased frequency of coronary artery disease (CAD), and that single nucleotide polymorphisms (SNPs) in the coding region of the ABCA1 gene significantly impact plasma lipid levels and the severity of CAD in the general population. They have now identified several SNPs in non‐coding regions of ABCA1 which may be important for the appropriate regulation of ABCA1 expression (i.e. in the promoter, intron 1 and the 5′ untranslated region), and have examined the phenotypic effects of these SNPs in the REGRESS population. Out of 12 SNPs, four were associated with a clinical outcome. A threefold increase in coronary events with an increased family history of CAD was evident for the G‐191C variant. Similarly, the C69T SNP was associated with a twofold increase in events. In contrast, the C‐17G was associated with a decrease in coronary events and the InsG319 was associated with less atherosclerosis. For all these SNPs, the changes in atherosclerosis and CAD occurred without detectable changes in plasma lipid levels. These data suggest that common variation in non‐coding regions of ABCA1 may significantly alter the severity of atherosclerosis, without necessarily influencing plasma lipid levels.</description><identifier>ISSN: 0009-9163</identifier><identifier>EISSN: 1399-0004</identifier><identifier>DOI: 10.1034/j.1399-0004.2002.610206.x</identifier><identifier>PMID: 11940086</identifier><identifier>CODEN: CLGNAY</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science, Ltd</publisher><subject>5' Untranslated Regions ; ABCA1 ; ATP Binding Cassette Transporter 1 ; ATP-Binding Cassette Transporters - genetics ; Biological and medical sciences ; Cardiology. Vascular system ; Cohort Studies ; coronary artery disease ; Coronary Artery Disease - genetics ; Coronary heart disease ; Gene Expression Regulation ; Heart ; Humans ; lipids ; Lipids - blood ; Male ; Medical sciences ; Models, Genetic ; Mutation ; Phenotype ; Polymorphism, Restriction Fragment Length ; Polymorphism, Single Nucleotide ; polymorphisms ; Promoter Regions, Genetic ; Random Allocation ; risk factors ; Time Factors</subject><ispartof>Clinical genetics, 2002-02, Vol.61 (2), p.115-125</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4386-abe807cb67acf1d404a9c8b97a2a7bf461b8ab507216c6c1ef3916f15b6aa9823</citedby><cites>FETCH-LOGICAL-c4386-abe807cb67acf1d404a9c8b97a2a7bf461b8ab507216c6c1ef3916f15b6aa9823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13573360$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11940086$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zwarts, KY</creatorcontrib><creatorcontrib>Clee, SM</creatorcontrib><creatorcontrib>Zwinderman, AH</creatorcontrib><creatorcontrib>Engert, JC</creatorcontrib><creatorcontrib>Singaraja, R</creatorcontrib><creatorcontrib>Loubser, O</creatorcontrib><creatorcontrib>James, E</creatorcontrib><creatorcontrib>Roomp, K</creatorcontrib><creatorcontrib>Hudson, TJ</creatorcontrib><creatorcontrib>Jukema, JW</creatorcontrib><creatorcontrib>Kastelein, JJP</creatorcontrib><creatorcontrib>Hayden, MR</creatorcontrib><title>ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels</title><title>Clinical genetics</title><addtitle>Clin Genet</addtitle><description>The authors have previously shown that individuals heterozygous for ABCA1 mutations have decreased high density lipoprotein cholesterol, increased triglycerides and an increased frequency of coronary artery disease (CAD), and that single nucleotide polymorphisms (SNPs) in the coding region of the ABCA1 gene significantly impact plasma lipid levels and the severity of CAD in the general population. They have now identified several SNPs in non‐coding regions of ABCA1 which may be important for the appropriate regulation of ABCA1 expression (i.e. in the promoter, intron 1 and the 5′ untranslated region), and have examined the phenotypic effects of these SNPs in the REGRESS population. Out of 12 SNPs, four were associated with a clinical outcome. A threefold increase in coronary events with an increased family history of CAD was evident for the G‐191C variant. Similarly, the C69T SNP was associated with a twofold increase in events. In contrast, the C‐17G was associated with a decrease in coronary events and the InsG319 was associated with less atherosclerosis. For all these SNPs, the changes in atherosclerosis and CAD occurred without detectable changes in plasma lipid levels. These data suggest that common variation in non‐coding regions of ABCA1 may significantly alter the severity of atherosclerosis, without necessarily influencing plasma lipid levels.</description><subject>5' Untranslated Regions</subject><subject>ABCA1</subject><subject>ATP Binding Cassette Transporter 1</subject><subject>ATP-Binding Cassette Transporters - genetics</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cohort Studies</subject><subject>coronary artery disease</subject><subject>Coronary Artery Disease - genetics</subject><subject>Coronary heart disease</subject><subject>Gene Expression Regulation</subject><subject>Heart</subject><subject>Humans</subject><subject>lipids</subject><subject>Lipids - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Models, Genetic</subject><subject>Mutation</subject><subject>Phenotype</subject><subject>Polymorphism, Restriction Fragment Length</subject><subject>Polymorphism, Single Nucleotide</subject><subject>polymorphisms</subject><subject>Promoter Regions, Genetic</subject><subject>Random Allocation</subject><subject>risk factors</subject><subject>Time Factors</subject><issn>0009-9163</issn><issn>1399-0004</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqNkUGP0zAQhS0EYsvCX0DhALcEO04c-0a3XQpSBQdAHK2JM0YubhLsZOn-e1yl2r1y8bM13zx7ngl5w2jBKK_eHwrGlcoppVVRUloWgtGSiuL0hKweKk_JKonKFRP8iryI8ZCOvKnVc3LFmKoolWJF3Ppms2ZZwF-zh2kI99kdBAf9FDPXWz9jbzAzQxh6SDUIEybpXESImIgOR0xLP2WDzdBaNKlx6LPRQzxC5t3ouszjHfr4kjyz4CO-uug1-fHx9vvmU77_uvu8We9zU3EpcmhR0sa0ogFjWVfRCpSRrWqghKa1lWCthLamTcmEEYah5WlCy-pWAChZ8mvybvEdw_Bnxjjpo4sGvYcehznqhtVSKlknUC2gCUOMAa0egzumMTWj-pyzPuhzmvqcpj7nrJec9Sn1vr5cMrdH7B47L8Em4O0FgGjA2wC9cfGR43XDuaCJ-7Bwf53H-_9_gd7sbpd9ssgXCxcnPD1YQPitRZM-XP_8stPf6HYr94LrLf8HlPKppQ</recordid><startdate>200202</startdate><enddate>200202</enddate><creator>Zwarts, KY</creator><creator>Clee, SM</creator><creator>Zwinderman, AH</creator><creator>Engert, JC</creator><creator>Singaraja, R</creator><creator>Loubser, O</creator><creator>James, E</creator><creator>Roomp, K</creator><creator>Hudson, TJ</creator><creator>Jukema, JW</creator><creator>Kastelein, JJP</creator><creator>Hayden, MR</creator><general>Blackwell Science, Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200202</creationdate><title>ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels</title><author>Zwarts, KY ; Clee, SM ; Zwinderman, AH ; Engert, JC ; Singaraja, R ; Loubser, O ; James, E ; Roomp, K ; Hudson, TJ ; Jukema, JW ; Kastelein, JJP ; Hayden, MR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4386-abe807cb67acf1d404a9c8b97a2a7bf461b8ab507216c6c1ef3916f15b6aa9823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>5' Untranslated Regions</topic><topic>ABCA1</topic><topic>ATP Binding Cassette Transporter 1</topic><topic>ATP-Binding Cassette Transporters - genetics</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cohort Studies</topic><topic>coronary artery disease</topic><topic>Coronary Artery Disease - genetics</topic><topic>Coronary heart disease</topic><topic>Gene Expression Regulation</topic><topic>Heart</topic><topic>Humans</topic><topic>lipids</topic><topic>Lipids - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Models, Genetic</topic><topic>Mutation</topic><topic>Phenotype</topic><topic>Polymorphism, Restriction Fragment Length</topic><topic>Polymorphism, Single Nucleotide</topic><topic>polymorphisms</topic><topic>Promoter Regions, Genetic</topic><topic>Random Allocation</topic><topic>risk factors</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zwarts, KY</creatorcontrib><creatorcontrib>Clee, SM</creatorcontrib><creatorcontrib>Zwinderman, AH</creatorcontrib><creatorcontrib>Engert, JC</creatorcontrib><creatorcontrib>Singaraja, R</creatorcontrib><creatorcontrib>Loubser, O</creatorcontrib><creatorcontrib>James, E</creatorcontrib><creatorcontrib>Roomp, K</creatorcontrib><creatorcontrib>Hudson, TJ</creatorcontrib><creatorcontrib>Jukema, JW</creatorcontrib><creatorcontrib>Kastelein, JJP</creatorcontrib><creatorcontrib>Hayden, MR</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zwarts, KY</au><au>Clee, SM</au><au>Zwinderman, AH</au><au>Engert, JC</au><au>Singaraja, R</au><au>Loubser, O</au><au>James, E</au><au>Roomp, K</au><au>Hudson, TJ</au><au>Jukema, JW</au><au>Kastelein, JJP</au><au>Hayden, MR</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels</atitle><jtitle>Clinical genetics</jtitle><addtitle>Clin Genet</addtitle><date>2002-02</date><risdate>2002</risdate><volume>61</volume><issue>2</issue><spage>115</spage><epage>125</epage><pages>115-125</pages><issn>0009-9163</issn><eissn>1399-0004</eissn><coden>CLGNAY</coden><abstract>The authors have previously shown that individuals heterozygous for ABCA1 mutations have decreased high density lipoprotein cholesterol, increased triglycerides and an increased frequency of coronary artery disease (CAD), and that single nucleotide polymorphisms (SNPs) in the coding region of the ABCA1 gene significantly impact plasma lipid levels and the severity of CAD in the general population. They have now identified several SNPs in non‐coding regions of ABCA1 which may be important for the appropriate regulation of ABCA1 expression (i.e. in the promoter, intron 1 and the 5′ untranslated region), and have examined the phenotypic effects of these SNPs in the REGRESS population. Out of 12 SNPs, four were associated with a clinical outcome. A threefold increase in coronary events with an increased family history of CAD was evident for the G‐191C variant. Similarly, the C69T SNP was associated with a twofold increase in events. In contrast, the C‐17G was associated with a decrease in coronary events and the InsG319 was associated with less atherosclerosis. For all these SNPs, the changes in atherosclerosis and CAD occurred without detectable changes in plasma lipid levels. These data suggest that common variation in non‐coding regions of ABCA1 may significantly alter the severity of atherosclerosis, without necessarily influencing plasma lipid levels.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science, Ltd</pub><pmid>11940086</pmid><doi>10.1034/j.1399-0004.2002.610206.x</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-9163
ispartof Clinical genetics, 2002-02, Vol.61 (2), p.115-125
issn 0009-9163
1399-0004
language eng
recordid cdi_proquest_miscellaneous_71588985
source Wiley
subjects 5' Untranslated Regions
ABCA1
ATP Binding Cassette Transporter 1
ATP-Binding Cassette Transporters - genetics
Biological and medical sciences
Cardiology. Vascular system
Cohort Studies
coronary artery disease
Coronary Artery Disease - genetics
Coronary heart disease
Gene Expression Regulation
Heart
Humans
lipids
Lipids - blood
Male
Medical sciences
Models, Genetic
Mutation
Phenotype
Polymorphism, Restriction Fragment Length
Polymorphism, Single Nucleotide
polymorphisms
Promoter Regions, Genetic
Random Allocation
risk factors
Time Factors
title ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A47%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ABCA1%20regulatory%20variants%20influence%20coronary%20artery%20disease%20independent%20of%20effects%20on%20plasma%20lipid%20levels&rft.jtitle=Clinical%20genetics&rft.au=Zwarts,%20KY&rft.date=2002-02&rft.volume=61&rft.issue=2&rft.spage=115&rft.epage=125&rft.pages=115-125&rft.issn=0009-9163&rft.eissn=1399-0004&rft.coden=CLGNAY&rft_id=info:doi/10.1034/j.1399-0004.2002.610206.x&rft_dat=%3Cproquest_cross%3E71588985%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4386-abe807cb67acf1d404a9c8b97a2a7bf461b8ab507216c6c1ef3916f15b6aa9823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71588985&rft_id=info:pmid/11940086&rfr_iscdi=true